A look at what Health.com editors are reading this week
July 15, 2011
- You don’t need to spend all day working over a hot stove; try these no-bake, no-hassle desserts! Added bonus: The ingredients for each sweet treat will cost you less than $3 per serving. [AllYou]
- The incidence of diabetes is rising fast in the U.S. Read this cautionary tale about why you should make healthy lifestyle choices, so you don’t let type 2 get the best of you. [DailySpark]
- Don’t get stuck in a gym rut—it’s a long climb back out. Instead, try these five tips to keep your cardio routine fresh and fun. [FitSugar]
November 22, 2010
Getty Images
By Amanda Gardner
MONDAY, November 22 (Health.com) — Diabetes and depression often occur together, but it’s always been a chicken-or-egg scenario. Does diabetes make people depressed or are depressed people more likely to develop diabetes? Now a large new study suggests it’s both.
People with diabetes have a higher risk for developing depression than those without the chronic condition and those who are depressed are more likely to develop type 2 diabetes, according to a report in the November 22 issue of Archives of Internal Medicine. Read More
June 14, 2010
Istockphoto
By Denise Mann
MONDAY, JUNE 14 (Health.com) — The next time you order Chinese food or need a side dish to serve with dinner, you’re better off choosing brown rice instead of white. Eating more brown rice and cutting back on white rice may reduce your risk of diabetes, a new study reports. Read More
April 23, 2010
FRIDAY, April 23 (HealthDay News) — Patients with type 2 diabetes who can’t control their blood glucose levels with the drug metformin alone do better after adding injections of the drug liraglutide compared to oral doses of another drug called sitagliptin, researchers report.
In the study, Dr. Richard E. Pratley, of the University of Vermont College of Medicine in Burlington, and his colleagues randomly assigned patients whose blood glucose wasn’t sufficiently controlled by metformin (Glucophage) to receive 26 weeks of treatment with liraglutide (Victoza) by injection or sitagliptin (Januvia) by mouth. Read More
March 29, 2010
MONDAY, March 29 (HealthDay News) — Type 2 diabetics newly diagnosed with cancer have an increased risk of dying in the month following their cancer surgery, compared to people who are battling cancer alone.
This was particularly true for diabetics with colorectal or esophageal cancers, Johns Hopkins researchers found. Read More
March 24, 2010
WEDNESDAY, March 24 (HealthDay News) — Researchers have identified two gene variants that increase the risk of both the most common chronic liver disease in the United States as well as type 2 diabetes.
People who carry the variants of a gene for apolipoprotein C3 (APOC3), which produces an enzyme important in fat metabolism, have a higher incidence of nonalcoholic fatty liver disease and also insulin resistance, according to a report in the March 25 issue of the New England Journal of Medicine. The research group was led by Dr. Gerald I. Shulman, a professor of physiological chemistry, medicine and cellular and molecular physiology at Yale University. Read More
March 15, 2010
SUNDAY, March 14 (HealthDay News) — Two sets of results from a large U.S. government-sponsored trial find that neither aggressive treatment of cholesterol nor of blood pressure lowers the risk of heart events in people with type 2 diabetes.
“These results could be disappointing to a lot of people — that this intensive blood pressure control or intensive lipid control didn’t reduce fatal or nonfatal events,” said Dr. Stephen Kopecky, a cardiologist and professor of medicine at the Mayo Clinic in Rochester, Minn. Read More
February 22, 2010
MONDAY, Feb. 22 (HealthDay News) — The U.S. Food and Drug Administration on Monday said it was still reviewing documents that examine whether the blockbuster type 2 diabetes drug Avandia raises users’ odds for heart attack and heart failure and should be removed from the market.
In an an agency statement, health officials said they are looking at data from a large, long-term clinical study known as RECORD to see if there are possible heart risks with rosiglitazone (Avandia), although they are also reviewing the results of several observational studies on the cardiovascular safety of Avandia. Read More
February 5, 2010
FRIDAY, Feb. 5 (HealthDay News) — Scientists have completed a map of areas of the human genome that control which genes are switched on or off in type 2 diabetes, a finding that may advance understanding of the genetic basis of this and other common diseases.
“Most of the human genome is uncharted territory — entire stretches of sequence with no clear function or purpose,” study co-senior author Jason Lieb, an associate professor of biology at the University of North Carolina at Chapel Hill, said in a news release. Read More
January 26, 2010
TUESDAY, Jan. 26 (HealthDay News) — Victoza (liraglutide) has been approved to treat type 2 diabetes in some adults, the U.S. Food and Drug Administration said in a news release.
But the agency warned that the once-daily injection shouldn’t be used as an initial (first-line) treatment until additional studies are completed, since the drug may cause thyroid tumors or a rare disease called medullary thyroid cancer. People at risk for this type of cancer shouldn’t use the drug, the FDA stressed. Read More
